FDA puts on hold two drug trials of Rapt Therapeutics in ‘major setback’ Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The patient had a drug allergy to Dupixent, Regeneron and Sanofi’s drug for the conditions, and had also undergone thyroid hormone replacement therapy for an autoimmune condition called Hashimoto’s disease, CEO Brian Wong said in a conference call., The patient had a drug allergy to Dupixent, Regeneron and Sanofi’s drug for the conditions, and had also undergone thyroid hormone replacement therapy for an autoimmune condition called Hashimoto’s disease, CEO Brian Wong said in a conference call., , Read More